LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Mutated herpes simplex virus type 1 thymidine kinases and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutated HOXB4 proteins with improved stability, and methods...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Mutated steroid hormone receptors, methods for their use and mol

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutations in the gene encoding the alpha chain of platelet glyco

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Mutations of E cadherin as a basis for the diagnosis and...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Mutations of E cadherin as a basis for the diagnosis and...

Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases

Mutations rendering platelet glycoprotein IB .alpha. less reacti

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of bilin-binding protein

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of epidermal growth factor exhibiting enhanced...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of fibroblast growth factor 21

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of fibroblast growth factor 21

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of fibroblast growth factor 21

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of human epidermal growth factor exhibiting enhanced bin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of human erythropoietin, the preparation thereof and the

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon

Muteins of IFN-.beta.

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of IFN-.beta.

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...

Muteins of placental growth factor type I, preparation...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of the CGRP 1-7 peptide fragment and use thereof as...

Drug – bio-affecting and body treating compositions – Lymphokine

Muteins of the granulocyte colony stimulating factor